Raised millions to develop a treatment for ´butterfly children´

Fragile as a butterfly’s wing – that’s how people living with Epidermolysis Bullosa are usually described. The Lund-based company Xinnate recently raised SEK 10...

GU Ventures AB

Specific proposals and targets top the universities’ desired priorities

What are the universities’ expectations for the update of the national life science strategy? Life Science Sweden posed the question to representatives from Kar...

Mercodia AB

ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics

Live imaging with uniform super-resolution in all spatial dimensions.

Västsvenskt biotechbolag blir del av tysk koncern – ”En perfekt match”

Svenska Envue Technologies blir en del av tyska Nanotemper.

Swedish and Ukrainian Medical Product Agencies sign an agreement

The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.

Here are the pharmaceutical companies best prepared for AI

How well prepared are pharmaceutical companies in the field of artificial intelligence? That is what a new analysis has tried to evaluate.

Phase III win for Hansa Biopharma: “We Are Thrilled”

Swedish biotech Hansa Biopharma’s transplant drug imlifidase has met the primary efficacy endpoint in a registration-enabling Phase III study in the United States.

Saniona licensierar ut epilepsiprogram – aktien rusar

Läkemedelsutvecklaren Saniona har ingått ett licensavtal med Jazz Pharmaceuticals om ett läkemedel i preklinisk fas för epilepsi. Beskedet fick aktien att stiga...

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

Unmatched performance and flexibility in its class

The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.

Malmös forskningspark Medeon får ny vd

Malmös forskningspark för life science har rekryterat Malin Bornschein till ny vd.

The Swedish Life Science Office: “We lost in both coordination and manpower”

Since the turn of the year, the Swedish government’s life science office has operated at a lower capacity. Life Science Sweden has spoken to Pontus Holm, Depart...

Meet us at Control 2025

Innovations that drive efficiency.

Lilly recruits top Swedish researcher in Alzheimer´s

One of Sweden's leading Alzheimer's researchers, Oskar Hansson, has been recruited by pharma giant Eli Lilly and will be moving to the USA.

Ny Leqembi-data antyder upp till åtta år fördröjd sjukdomsprogression

Ju tidigare lecenemab sätts in, desto större effekt kan den ha på att bromsa Alzheimers sjukdom. Det antyder nya modellerade prognoser som Bioartics partner Eisai presenterat.

ZEISS Metrology Shop provides planning security

ZEISS Metrology Shop brings it all together.

CCRM Nordic gör sin första investering – i Kubistas nya analysbolag

Göteborgsbaserade Precision Bioanalytics blir det första bolaget som får en strategisk investering från CCRM Nordic. Ambitionen är att driva på utvecklingen av ...

Efter förseningen – nu lämnar Xspray in uppdaterad FDA-ansökan

Forskningsbolaget Xspray Pharma har nu lämnat in en uppdaterad FDA-ansökan om godkännande för leukemibehandlingen Dasynoc.

Study: Cancer vaccine prolongs survival in difficult-to-treat tumour disease

According to a new study, a combination of a cancer vaccine from Norwegian company Ultimovacs and two immunotherapies significantly prolonged survival in cases ...

Southern Swedish company Aqilion develops drug for eosinophilic esophagitis

When Aqilion began developing a drug for eosinophilic esophagitis, the molecule was classified as an orphan drug. But the prevalence of the disease now appears ...

Radioactive tracer to measure effect of drug towards Crohn’s disease

A radioactive tracer developed by Astra Zeneca and the Karolinska Institutet may play a major role for patients with Crohn's disease. That is the belief of Mari...

The fast route to a safe insulin pen

Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...